Tewari KS - Search Results

1

First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826.

Monk BJ, Colombo N, Tewari KS, Dubot C, Caceres MV, Hasegawa K, Shapira-Frommer R, Salman P, Yañez E, Gümüş M, Olivera Hurtado de Mendoza M, Samouëlian V, Castonguay V, Arkhipov A, Tekin C, Li K, Keefe SM, Lorusso D; KEYNOTE-826 Investigators. Monk BJ, et al. Among authors: tewari ks. J Clin Oncol. 2023 Dec 20;41(36):5505-5511. doi: 10.1200/JCO.23.00914. Epub 2023 Nov 1. J Clin Oncol. 2023. PMID: 37910822

2

Does perioperative blood transfusion affect survival in patients with cervical cancer treated with radical hysterectomy?

Monk BJ, Tewari K, Gamboa-Vujicic G, Burger RA, Manetta A, Berman ML. Monk BJ, et al. Obstet Gynecol. 1995 Mar;85(3):343-8. doi: 10.1016/0029-7844(94)00398-W. Obstet Gynecol. 1995. PMID: 7862369 Clinical Trial.

3

Open interstitial brachytherapy for the treatment of local-regional recurrences of uterine corpus and cervix cancer after primary surgery.

Monk BJ, Walker JL, Tewari K, Ramsinghani NS, Nisar Syed AM, DiSaia PJ. Monk BJ, et al. Gynecol Oncol. 1994 Feb;52(2):222-8. doi: 10.1006/gyno.1994.1035. Gynecol Oncol. 1994. PMID: 8314143

4

A comparison of intracavitary versus interstitial irradiation in the treatment of cervical cancer.

Monk BJ, Tewari K, Burger RA, Johnson MT, Montz FJ, Berman ML. Monk BJ, et al. Gynecol Oncol. 1997 Dec;67(3):241-7. doi: 10.1006/gyno.1997.4877. Gynecol Oncol. 1997. PMID: 9441770

5

Interstitial brachytherapy in the treatment of advanced and recurrent vulvar cancer.

Tewari K, Cappuccini F, Syed AM, Puthawala A, DiSaia PJ, Berman ML, Manetta A, Monk BJ. Tewari K, et al. Am J Obstet Gynecol. 1999 Jul;181(1):91-8. doi: 10.1016/s0002-9378(99)70441-2. Am J Obstet Gynecol. 1999. PMID: 10411801

6

Development and assessment of a general theory of cervical carcinogenesis utilizing a severe combined immunodeficiency murine-human xenograft model.

Tewari KS, Taylor JA, Liao SY, DiSaia PJ, Burger RA, Monk BJ, Hughes CC, Villarreal LP. Tewari KS, et al. Gynecol Oncol. 2000 Apr;77(1):137-48. doi: 10.1006/gyno.2000.5729. Gynecol Oncol. 2000. PMID: 10739703

7

Vaginal hysterectomy as primary treatment of endometrial cancer in medically compromised women.

Chan JK, Lin YG, Monk BJ, Tewari K, Bloss JD, Berman ML. Chan JK, et al. Obstet Gynecol. 2001 May;97(5 Pt 1):707-11. Obstet Gynecol. 2001. PMID: 11339920

8

Treatment of recurrent gynecologic malignancies with iodine-125 permanent interstitial irradiation.

Monk BJ, Tewari KS, Puthawala AA, Syed AM, Haugen JA, Burger RA. Monk BJ, et al. Among authors: tewari ks. Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):806-15. doi: 10.1016/s0360-3016(01)02728-6. Int J Radiat Oncol Biol Phys. 2002. PMID: 11849805

9

Conservation of in vitro drug resistance patterns in epithelial ovarian carcinoma.

Tewari KS, Mehta RS, Burger RA, Yu IR, Kyshtoobayeva AS, Monk BJ, Manetta A, Berman ML, Disaia PJ, Fruehauf JP. Tewari KS, et al. Gynecol Oncol. 2005 Sep;98(3):360-8. doi: 10.1016/j.ygyno.2005.04.036. Gynecol Oncol. 2005. PMID: 16000215

10

Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancer.

Tewari KS, Monk BJ. Tewari KS, et al. Curr Oncol Rep. 2005 Nov;7(6):419-34. doi: 10.1007/s11912-005-0007-z. Curr Oncol Rep. 2005. PMID: 16221379 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

231 results

Search Page